| Primary |
| Anxiety |
50.0% |
| Epilepsy |
50.0% |
|
| Coma |
50.0% |
| Therapeutic Response Unexpected With Drug Substitution |
50.0% |
|
| Secondary |
| Product Used For Unknown Indication |
22.2% |
| Sedation |
19.0% |
| Depression |
17.5% |
| Anxiety |
9.5% |
| Hepatitis C |
6.3% |
| Neuralgia |
6.3% |
| Drug Use For Unknown Indication |
4.8% |
| Schizophrenia |
3.2% |
| Tooth Abscess |
3.2% |
| Depressed Mood |
1.6% |
| Diabetes Mellitus |
1.6% |
| Drug Dependence |
1.6% |
| Insomnia |
1.6% |
| Mental Disorder |
1.6% |
|
| Delirium |
11.8% |
| Weight Decreased |
11.8% |
| Completed Suicide |
5.9% |
| Inflammatory Bowel Disease |
5.9% |
| Poisoning |
5.9% |
| Posture Abnormal |
5.9% |
| Raynaud's Phenomenon |
5.9% |
| Somnolence |
5.9% |
| Subarachnoid Haemorrhage |
5.9% |
| Suicide Attempt |
5.9% |
| Syncope |
5.9% |
| Tachycardia |
5.9% |
| Thinking Abnormal |
5.9% |
| Thyroid Disorder |
5.9% |
| Wolff-parkinson-white Syndrome |
5.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.0% |
| Multiple Sclerosis |
11.3% |
| Anxiety |
11.0% |
| Depression |
5.8% |
| Pain |
5.2% |
| Smoking Cessation Therapy |
4.9% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Cardiac Disorder |
3.1% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Hypothyroidism |
3.1% |
| Convulsion |
2.8% |
| Hypertension |
2.8% |
| Asthma |
2.4% |
| Crohn's Disease |
2.4% |
| Blood Cholesterol Increased |
2.1% |
| Irritable Bowel Syndrome |
2.1% |
| Sleep Disorder |
2.1% |
| Aortic Valve Prolapse |
1.8% |
| Atrial Fibrillation |
1.8% |
| Nasopharyngitis |
1.8% |
|
| Rash |
9.6% |
| Speech Disorder |
9.6% |
| Pyrexia |
8.2% |
| Tremor |
8.2% |
| Weight Increased |
6.8% |
| Smoker |
5.5% |
| Tendon Injury |
5.5% |
| Vision Blurred |
5.5% |
| Drug Ineffective |
4.1% |
| Respiratory Distress |
4.1% |
| Thrombocytopenia |
4.1% |
| Toxic Epidermal Necrolysis |
4.1% |
| Weight Decreased |
4.1% |
| Withdrawal Syndrome |
4.1% |
| Electrocardiogram Abnormal |
2.7% |
| Gastrointestinal Haemorrhage |
2.7% |
| Headache |
2.7% |
| Impaired Healing |
2.7% |
| Inflammatory Bowel Disease |
2.7% |
| Injection Site Pruritus |
2.7% |
|
